Bharat Biotech is reportedly considering a 0 million initial public offering (IPO), according to Bloomberg. The move aims to raise capital for expansion and research in the biotechnology sector. While details like the offering size and timing remain fluid, the IPO could attract global investors seeking exposure to India's growing healthcare market. The development may influence US equity markets, as the company's listing could draw cross-border investment flows.
مباشر